A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
Clinical trial NCT05874193 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05874193
- Sponsor
- Cristiana Costa Chase, DO
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-05-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.